• Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades, and initiations, please see our analyst ratings page.
• Evercore ISI Group analyst Vijay Kumar upgraded Guardant Health Inc (NASDAQ:GH) from In-Line to Outperform and raised the price target from $95 to $160. Guardant Health shares closed at $129.14 on Tuesday. See how other analysts view this stock.
• BofA Securities analyst Ernesto Gabilondo upgraded Grupo Cibest SA ADR (NYSE:CIB) from Underperform to Neutral and raised the price target from $68 to $75. Grupo Cibest shares closed at $73.37 on Tuesday. See how other analysts view this stock.

Considering buying GH stock? Here’s what analysts think: